Is Curis Lifesciences Ltd halal to invest in?

According to Musaffa's Shariah screening methodology, Curis Lifesciences Ltd (CURIS.NS) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Curis Lifesciences Ltd a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Curis Lifesciences Ltd using these criteria to determine its compliance status.

Can Muslims buy shares of Curis Lifesciences Ltd?

Muslim investors may consider investing in Curis Lifesciences Ltd if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Curis Lifesciences Ltd classified as NOT COVERED?

Musaffa determines the Shariah status of Curis Lifesciences Ltd by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Curis Lifesciences Ltd updated?

The Shariah compliance status of Curis Lifesciences Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Curis Lifesciences Ltd become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Curis Lifesciences Ltd?

You can check the latest Shariah compliance status of Curis Lifesciences Ltd on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Curis Lifesciences Ltd CURIS.NS

₹128.20

Last Updated: May 15, 12:00 AM·NSE

Curis Lifesciences Ltd. Stock Analysis CURIS.NS

India Health Care Nano Cap

Curis Lifesciences Ltd. engages in the manufacture, development, and distribution of pharmaceutical products. The company is headquartered in Ahmedabad, Gujarat. The company went IPO on 2025-11-14. The firm is engaged in the business of manufacturing a wide range of pharmaceutical products such as Tablets, Capsules, External Preparations, Oral Liquid, and Sterile Ophthalmic Ointments. The firm manufactures activities on loan license, Contract Manufacturing and Direct Export basis/Own Brand Marketing basis. Its products include general pharmaceutical tablets, general pharmaceutical capsules, general oral liquid, general external preparation, and sterile ophthalmic ointment. Its pharmaceutical tablets are solid dosage form of medication used for delivering active pharmaceutical ingredients. Its sterile ophthalmic ointment is a type of medication formulated for use in the eyes. Its oral liquid is versatile form of medication to be taken by mouth.

Key Statistics of Curis Lifesciences Ltd (CURIS.NS)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

₹128.20₹128.20

Today's Open

₹128.20

Volume

2000.00

P/E Ratio (TTM)

52 Week Range

₹83.60₹147.90

Market Cap

970.13M

Avg. Volume

6550.00

Dividend Yield

Financial Metrics & Statements of Curis Lifesciences Ltd (CURIS.NS)

FAQ's for Curis Lifesciences Ltd (CURIS.NS)

According to Musaffa’s Shariah screening methodology, Curis Lifesciences Ltd (CURIS.NS) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.